# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062822-12-000010
Filing Date
2012-03-08
Accepted
2012-03-07 17:38:48
Documents
16
Period of Report
2011-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | form10k12312011.htm | 10-K | 1698439
2 | EXHIBIT 10.5 | exh105-xlapuertaofferletter.htm | EX-10.5 | 26468
3 | EXHIBIT 10.10 | exh1010-xnamedexecutiveoff.htm | EX-10.10 | 17379
4 | EXHIBIT 10.15 | exh1015-xofficerstockoptio.htm | EX-10.15 | 33166
5 | EXHIBIT 10.16 | exh1016-xofficerrestricted.htm | EX-10.16 | 30436
6 | EXHIBIT 23.1 | exh231ernst_youngconsent10.htm | EX-23.1 | 8356
7 | EXHIBIT 31.1 | exh311certificationofprinc.htm | EX-31.1 | 16060
8 | EXHIBIT 31.2 | exh312certificationofprinc.htm | EX-31.2 | 16253
9 | EXHIBIT 32.1 | exh321certificationofprinc.htm | EX-32.1 | 9081
16 |  | a2011graph3.jpg | GRAPHIC | 29022
| Complete submission text file | 0001062822-12-000010.txt |  | 5315127

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL INSTANCE DOCUMENT | lxrx-20111231.xml | EX-101.INS | 704659
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lxrx-20111231.xsd | EX-101.SCH | 22394
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lxrx-20111231_cal.xml | EX-101.CAL | 45433
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lxrx-20111231_def.xml | EX-101.DEF | 100569
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lxrx-20111231_lab.xml | EX-101.LAB | 254920
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lxrx-20111231_pre.xml | EX-101.PRE | 131796

Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30111 | Film No.: 12675227
SIC: 2834 Pharmaceutical Preparations